Cargando…

C5a receptor expression on leukocytes from patients with severe sepsis or septic shock

Detalles Bibliográficos
Autores principales:	Furebring, M, Håkansson, L, Venge, P, Siegbahn, A, Nilsson, B, Sjölin, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333252/ http://dx.doi.org/10.1186/cc1132

Ejemplares similares

Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis
por: Furebring, Mia, et al.
Publicado: (2002)

Mobilization of leukocytes in patients with severe sepsis and septic shock is associated with increased apoptosis, as detected by Annexin V binding
por: Weiss, M, et al.
Publicado: (2001)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

Prognostic value of the bone marrow in severe sepsis/septic shock
por: Milheiro, R, et al.
Publicado: (1999)

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

Phagocytosis of granulocytes is decreased in most patients with severe sepsis or septic shock
por: Fischer, G, et al.
Publicado: (2000)

Acidosis and mortality in severe sepsis and septic shock evaluated by base excess variation
por: Palma, LC, et al.
Publicado: (2003)

How well does TOKS identify patients with severe sepsis or septic shock?
por: Tanderup, Anette, et al.
Publicado: (2013)

Impact of socioeconomic status on mortality and morbidity in patients with severe sepsis and septic shock
por: Schnegelsberg, Amal, et al.
Publicado: (2015)

Cost-effectiveness of early goal-directed therapy in the treatment of severe sepsis and septic shock
por: Huang, DT, et al.
Publicado: (2003)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Arterio- and veno-venosus hemofiltration in the treatment of sepsis and septic shock
por: Marjanek, Zs, et al.
Publicado: (2002)

Sublingual leukocyte activation in patients with severe sepsis or septic shock
por: Fabian-Jessing, BK, et al.
Publicado: (2015)

Peaks in G-CSF serum concentrations are accompanied by an increase in phagocytotic activity in most patients with severe sepsis or septic shock
por: Fischer, G, et al.
Publicado: (2001)

Severity stratification of septic shock according to noradrenaline requirement
por: Hernández, G, et al.
Publicado: (2001)

Severity stratification of septic shock according to noradrenaline requirement
por: Hernández, G, et al.
Publicado: (2001)

Usefulness of intrathoracic blood volume in the early phase of hemodynamic instability of patients with sepsis or septic shock
por: Sakka, SG, et al.
Publicado: (1999)

Hypocalcemia in children with septic shock
por: Buysse, CMP, et al.
Publicado: (2001)

Preload assessment in septic shock
por: Donati, A, et al.
Publicado: (2000)

Urine Hydrogen Peroxide Levels and Their Relation to Outcome in Patients with Sepsis, Septic Shock, and Major Burn Injury
por: Lipcsey, Miklos, et al.
Publicado: (2022)

Procalcitonin serum concentrations do not differentiate severity of septic shock in postoperative patients
por: Weiss, M, et al.
Publicado: (2000)

Norepinephrine requirement is not an independent variable to predict outcome in severe septic shock patients
por: Silva, E, et al.
Publicado: (2002)

Myocardial cell injury in septic shock
por: Rodrigues, MG, et al.
Publicado: (2003)

Secretory phospholipase A2 (sPLA2), procalcitonin (PCT) and C-reactive protein (CRP) for the diagnosis and differentiation of septic shock and non-septic shock
por: Anglès, O, et al.
Publicado: (2000)

Is β-adrenergic receptor stimulation crucial for splanchnic O(2) availability in septic shock?
por: Reinelt, H, et al.
Publicado: (1997)

Terlipressin in the treatment of catecholamine resistant septic shock
por: Auzinger, GM, et al.
Publicado: (2002)

Septic shock etiology in kidney transplant recipients
por: De Marco, FVC, et al.
Publicado: (2002)

Determinants of natriuretic peptides in early septic shock
por: Witthaut, R, et al.
Publicado: (1998)

Severe Sepsis and Septic Shock
por: Opal, Steven M.
Publicado: (2008)

Plasmafiltration in septic shock: a review of 15 cases
por: Campos, P, et al.
Publicado: (2003)

C1-Inhibitor substitution as ultima ratio therapy in septic shock: experience with 15 patients
por: Vangerow, B, et al.
Publicado: (1998)

Increased leukocyte oxidative metabolism in severe sepsis and septic shock correlates with organ dysfunction and mortality
por: Martins, P, et al.
Publicado: (2006)

Role of decisive markers in diagnosis and outcome of patients with septic shock
por: Rizk, A, et al.
Publicado: (2000)

Hemodynamic effects of the inspiratory flow rate in patients with septic shock
por: Koroneos, A, et al.
Publicado: (2000)

Advantages of ultrasound in the emergency room in a septic shock patient
por: Algaba-Montes, M, et al.
Publicado: (2015)

Continuous hemodiafiltration with bicarbonate- and lactate-buffered replacement fluids in septic shock
por: Lewejohann, J-C, et al.
Publicado: (1999)

Diagnostic determinants for capillary leakage syndrome (CLS) in septic shock patients
por: Marx, G, et al.
Publicado: (1999)

Renal effect of dopamine, norepinephrine, epinephrine, or norepinephrine–dobutamine in septic shock
por: Qiu, HB, et al.
Publicado: (2002)

Effects of epinephrine compared to dobutamine-norepinephrine on gastric perfusion in septic shock
por: Seguin, P, et al.
Publicado: (2002)

Coupled plasmafiltration-adsorption (CPFA) in septic shock with normal renal function
por: Livigni, S, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_t9fluihsj3bj5h4fk047ko7rn4